[1] Emerging Risk Collaboration, Kaptoge S, Di Angelantonio E, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis[J] . Lancet , 2010, 375(9709):132-140.
[2] Mendall MA, Patel P, Ballam L, et al. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study[J] . BMJ, 1996, 312(7038):1061-1065.
[3] Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association[J] . Circulation, 2003, 107(3):499-511.
[4] Dhingra R, Gona P, Nam BH, et al. C-reactive protein, inflammatory conditions, and cardiovascular disease risk[J] . Am J Med, 2007, 120(12): 1054-1062.
[5] 李岚岚,涂干卿.超敏C反应蛋白与血脂联合检测在冠心病中的临床价值[J] . 国际检验医学杂志,2009,30(10):963-964.
[6] 高 红,周晶萍,王象勇.冠心病患者血清超敏CRP与血脂联合检测的临床意义[J] . 陕西医学杂志,2008, 3(10):1409-1410.
[7] Lakoski SG, Cushman M, Criqui M, et al. Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort[J] . Am Heart J, 2006, 152 (3):593-598. |
